UTAH STATE UNIVERSITY - Coronavirus Contracts

Contracts Vendors Agencies Categories States

Coronavirus Contracts

Tracking Federal Purchases to Fight the Coronavirus

Home › All Vendors › Vendor ›

UTAH STATE UNIVERSITY

Total Committed Value of Federal Contracts

$1.71M

Total Contracts

Total Actions

Location

Logan, UT

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description	Category	Agency	Signed	Amount Committed
PERFORM HIGH THROUGHPUT IN VIVO EFFICACY TESTING OF THERAPEUTIC CANDIDATES AGAINST SARS-COV-2	Biomedical R&D	National Institutes of Health	March 29, 2021	$379,235
THE CONTRACTOR SHALL DETERMINE THE ANTIVIRAL INHIBITORY ACTIVITY AND CYTOTOXICITY OF TEST MOLECULES AGAINST RESPIRATORY VIRUSES USING THE SPECIFIED TEST METHOD TO IDENTIFY ACTIVE TEST MOLECULES FOR FURTHER INVESTIGATION.	Biomedical R&D	National Institutes of Health	July 28, 2020	$0
UTAH STATE UNIVERSITY (USU) SHALL SUPPORT NASA MARSHALL SPACE FLIGHT CENTER (MSFC) AS DEFINED IN THIS DOCUMENT. USU SHALL PROVIDE THE LANGMUIR PROBE, IMPEDANCE PROBE, ELECTRIC FIELD PROBE, STAR CAMERA AND TECHNICAL EXPERTISE AND ASSESSMENT SUPPORT SERVICES FOR THE SCINTILLATION PREDICTION OBSERVATIONS RESEARCH TASK (SPORT).	Other Engineering Development R&D	National Aeronautics and Space Administration	July 15, 2020	$26,283
THE CONTRACTOR SHALL DETERMINE THE ANTIVIRAL INHIBITORY ACTIVITY AND CYTOTOXICITY OF TEST MOLECULES AGAINST RESPIRATORY VIRUSES USING THE SPECIFIED TEST METHOD TO IDENTIFY ACTIVE TEST MOLECULES FOR FURTHER INVESTIGATION.	Biomedical R&D	National Institutes of Health	June 26, 2020	$354,750
COVID-19: TO DETERMINE THE ANTIVIRAL INHIBITORY ACTIVITY AND CYTOTOXICITY OF TEST MOLECULES AGAINST RESPIRATORY VIRUSES LISTED IN ONE OR MORE OF THE GROUPS BELOW USING THE SPECIFIED TEST METHOD TO IDENTIFY ACTIVE TEST MOLECULES FOR FURTHER INVESTIGAT	Biomedical R&D	National Institutes of Health	June 03, 2020	$0
COVID-19: TO DETERMINE THE ANTIVIRAL INHIBITORY ACTIVITY AND CYTOTOXICITY OF TEST MOLECULES AGAINST RESPIRATORY VIRUSES LISTED IN ONE OR MORE OF THE GROUPS BELOW USING THE SPECIFIED TEST METHOD TO IDENTIFY ACTIVE TEST MOLECULES FOR FURTHER INVESTIGAT	Biomedical R&D	National Institutes of Health	April 27, 2020	$9,072
STAT2 KO HAMSTERS	Live Animals Rental	National Institutes of Health	March 26, 2020	$16,000
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES: ESTABLISHMENT OF SMALL ANIMAL MODELS FOR SCREENING MCMS FOR THE 2019 NOVEL CORONAVIRUS (SARS-COV-2)	Biomedical R&D	National Institutes of Health	March 23, 2020	$921,951

See this vendor on usaspending.gov ›

About this data

This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.